Tumor immune microenvironment is a very complex system that is influenced by a wide
range of factors; in this microenvironment, various immune cells, stromal cells, and cytokines …

The clinical success of cancer immunotherapies targeting PD-1 and CTLA-4 has ignited a
substantial research effort to improve our understanding of tumor immunity. Recent studies …

Cancers develop complex and dynamic tissue microenvironments to support their sustained
growth, invasion and metastasis. For decades, rapid progress has been made in the cross …

Tumor immunotherapy is considered to be a novel and promising therapy for tumors and it
has recently become a hot research topic. The clinical success of tumor immunotherapy has …

The tumor microenvironment plays a critical role in cancer development, progression, and
control. The molecular and cellular nature of the tumor immune microenvironment influences …

Tumor immunotherapy has achieved remarkable efficacy, with immune‐checkpoint
inhibitors as especially promising candidates for cancer therapy. However, some issues …

Despite advancements in tumor immunotherapy, inconsistent therapeutic effects and
barriers impacting clinical outcomes highlight the need for a better understanding of the …

Tumor immune microenvironment (TIME) include tumor cells, immune cells, cytokines, etc.
The interactions between these components, which are divided into anti-tumor and pro …

Modulation of the tumor microenvironment is becoming an increasingly popular research
topic in the field of immunotherapy, and studies regarding immune checkpoint blockades …

There is much promise in the use of immunotherapy for the treatment of cancer. Approaches
such as those using antibodies or adoptive cell transfer can mediate complete tumor …